Skip to main content

Table 1 Baselines characteristics.

From: Clinical evaluation of iron treatment efficiency among non-anemic but iron-deficient female blood donors: a randomized controlled trial

 

FeSO4 a

n = 74

Placebo

n = 71

Differencea

Absolute values

Age, mean years (SD)

32.9 (8.4)

30.7 (8.8)

2.1

Number of previous donations per year, n (%)

   

   None

26 (35.1%)

25 (35.2%)

-0.1%

   One

29 (39.2%)

31 (43.7%)

-4.5%

   Two

19 (25.7%)

15 (21.1%)

4.6%

Weight, mean kg (SD)

64.2 (10.7)

67.6 (13.3)

-3.4

Pictorial Bleeding Assessment chart

   

   Score > 185, n (%)

6 (8.2%)

9 (12.7%)

-4.5%a

Before donation; mean (SD)

   

   Visual analogue scale for fatigue

3.4 (2.4)

3.9 (2.6)

-0.6

   Fatigue severity scale

2.5 (1.1)

2.7 (1.2)

-0.2

   Hemoglobin, g/Lb

138 (6.3)

135 (7.5)

3

   Ferritin, ng/mLb

36.3 (22.4)

34.1 (15.0)

2.2

One week after donation; mean (SD)

   

   Visual analogue scale for fatigue

3.9 (2.3)

4.0 (2.4)

-0.02

   Fatigue severity scale

2.9 (1.3)

3.0 (1.4)

-0.1

   Vitality score (SF-12V2)c

53.1 (12.9)

55.9 (11.3)

-2.8

   Chester step test, mLO2/kg/min

37.0 (7.2)

36.9 (5.9)

0.1

   Hemoglobin, g/L

126 (5.2)

126 (5.3)

-0.02

   Ferritin, ng/mL

15.3 (7.7)

14.8 (7.3)

0.4

   C-reactive protein, mg/L

2.1 (2.9)

2.9 (3.5)

0.8

   Depression (PHQ-9), n (%)

4 (5.4%)

4 (5.7%)

-0.3%

   Mental health (SF-12NL)d

38.6 (4.4)

39.3 (5.3)

-0.7

   Physical condition (SF-12NL)d

53.7 (4.2)

53.6 (4.2)

0.09

  1. aClinically significant difference. P-values of differences were not calculated, since randomization and allocation ensured that any difference could only be due to chance. bHemoglobin and ferritin values before donation were not available for two donors from the control group. cOne donor from the intervention group and two from the control group did not answer the 10th question on the SF-12V2. dSF-12 was incomplete for three donors in each group. SD: standard deviation.